Bard Cancer Diagnostics: Global Recognition for Advanced Imaging and Early Detection

NEW YORK, Jan. 12, 2018 /PRNewswire/ -- January 7, 2018 marked the 46th year of Dr. Robert Bard’s practice and the launch of the “Bard Cancer Diagnostics” in midtown Manhattan- an internationally renowned facility for advanced detection and analysis of cancer tumors using the most current innovations and procedures.

Since 1972, Dr. Bard established a reputation in the medical field through his contributions in cancer imaging. His use of current technologies to diagnose tumors, ablate disease through X-rays, CT scans, PET scans and magnetic resonance imaging (MRI) scans & ultrasound equipment plus the specialized use of image guided modalities to kill cancerous tissues has positioned him as one of the most recognized American specialists in the industry.

“With proper technology, analyzing one’s disorders can be accomplished in a non-invasive way...” says Dr. Bard. “We can now determine pre-operatively significant information about one’s cancer... from a benign cyst under the skin or a growing malignancy, knowing how aggressive and how advanced the cancer is will help us establish an accurate and personalized treatment plan. For the patient, it’s immediate peace of mind when the 3D imaging establishes the diagnostic parameters during the examination as you see the pictures in front of you.”

Dr. Bard’s career has amassed a list of citations & honors from some of the most acclaimed medical societies in North America and Europe such as Mt Sinai Med School, the American Society of Lasers in Medicine & Surgery, Service d’Oncologie médicale - Hôpitaux Universitaires Pitié Salpêtrière (Paris) and the International Congress of Musculoskeletal Sonography (Prague). Beyond the practice, his knowledge in internal medicine is also widely published in over 80 medical texts, journals and 9+ books, spanning topics from Gynecology and Obstetrics, Prostate Cancer & Urology, Ophthalmic Disorders, Cardiovascular issues and Dermatologic studies.

Today’s Bard Cancer Diagnostics continues the original blueprint of using cutting edge imaging solutions such as the 3D Doppler Histogram Analysis technology and other innovations to battle cancer. His arsenal of high-end scanning solutions are recognized worldwide as one of the industry’s best answer to real-time, accurate and non-invasive diagnostic imaging. In addition, his 2018 projects include a major investment in educational media series on PREVENTION and a joint venture with various NY-based cancer experts offering a life-saving EARLY DETECTION program.

PHILANTHROPIC PURSUITS
Dec 22, 2017- Dr. Robert Bard was recently awarded a Regional Ambassadorship role by Awareness for a Cure (www.awarenessforacure.org), a public cancer resource under the international not-for-profit organization Best Answer for Cancer. His efforts have helped to bring new attention and media support to cancer charity events produced by groups such as the Leukemia & Lymphoma Society and the American Cancer Society. Dr. Bard’s active voice in social media reaches many allies and partners in the corporate and medical sectors. “My midtown office is the perfect location for fundraising and getting the right help for cancer charities ... this year, we’re excited about a great game plan to reach even more resources to assist cancer charities effectively”, says Dr. Bard. For more information, visit: www.BardCancerDiagnostics.com. Media contact: call Aimee Arceo at: 212.355.7017

View original content with multimedia:http://www.prnewswire.com/news-releases/bard-cancer-diagnostics-global-recognition-for-advanced-imaging-and-early-detection-300581647.html

SOURCE Bard Cancer Diagnostics